Search database
Filter
37
Text search: Chagas Coalition
Featured
Language
Document type
Studies & Reports
10
No document type
10
Resource Platforms
5
Strategic & Response Plan
4
Guidelines
3
Manuals
2
App
1
Videos
1
Fact sheets
1
Countries / Regions
Global
6
Latin America and the Carribbean
2
Ghana
1
Brazil
1
Africa
1
Venezuela
1
Authors & Publishers
Chagas Coalition
8
World Health Organization WHO
5
World Health Organization (WHO)
3
et al.
2
World Health Organisation (WHO)
2
World Heart Federation
2
Börjesson, E., Pedersen, K., & Villa Torres, L.
1
BUKO Pharma-Kampagne/Gesundheit und Dritte Welt e.V.
1
CODEVIDA, Coalición de Organizaciones por el Derecho a la Salud y a la Vida
1
DNDi - Drugs for neglected diseases initiative
1
F. Pérez
1
Fanjul, G.
1
Food and Agriculture Organization of the United Nations
1
Info Chagas
1
International Vaccines Task Force (IVTF)
1
Ipas
1
L. Sereno
1
M. B. Mello
1
Mas, F.
1
Ministry of Health Ghana
1
Moriana, S.
1
National Library of Medicine
1
Organisation mondiale de la Santé (OMS)
1
Oritz, G.
1
PAHO, WHO
1
Pan American Health Organisation PAHO
1
Pan American Health Organization
1
Pan American Health Organization PAHO
1
PROVEA , Programa Venezolano de Educación - Acción en Derechos Humanos
1
Research and reports in tropical medicine
1
Suárez, C., Nolder, D., García-Mingo, A. et al.
1
The Independent Panel
1
United Nations Enviroment Programme
1
Vengesai A., Naicker T., Kasambala M., et al.
1
WHO Africa
1
Wolrd Health Organization
1
World Health Organization (Americas)
1
World Health Organization Africa Region
1
World Organisation for Animal Health
1
Zaidel, E.J.
1
Publication Years
Category
Clinical Guidelines
7
Countries
3
Key Resources
3
Public Health
2
Capacity Building
1
Women & Child Health
1
Toolboxes
NTDs
16
HIV
3
Rapid Response
2
COVID-19
2
NCDs
2
Ebola
1
Global Health Education
1
Planetary Health
1
Pharmacy
1
Health Financing Toolbox
1
Not long ago, on the occasion of the 100th anniversary of the discovery of Chagas disease, several campaigns denounced the scant progress has been made in diffrent spheres- medical, scientific and politcal- but major challanges still remain. This is ... more
Chagas disease, which is caused by infection with the parasite Trypanosoma cruzi, is known as the silent disease. An estimated 8 million people have the disease and most of them do not know that they are infected.
Research and Reports in Tropical Medicine 2022:13 25–40. Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mo ... more
Global chagas coalitions members contributions
Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.
Info Chagas What do we need to know abaout Chagas Disease? What is Chagas Disease?
Two adjectives raise an issue for communicators working on Chagas disease (CD): “invisible and silent”. Two adjectives that can be ascribed to other neglected tropical diseases (NTD), but which are part of the essence of CD. Bringing CD out of i ... more
It is estimated that, in Latin America alone, between 6 and 8 million people are infected with the parasite, and 99% of these are not receiving treatment, either because they are unaware of their infection or because they do not know that treatment exists. The potential spread of the disease is also ... more
Chagas disease, which is caused by infection with the parasite Trypanosoma cruzi, is known as the silent disease. An estimated 8 million people have the disease and most of them do not know that they are infected.
Causada por el parásito Trypanosoma cruzi, la enfermedad de Chagas es una enfermedad silenciosa. Se estima que 8 millones de personas son portadoras y la mayoría no lo sabe.
This is a tool meant to share and train the healthcare workers with precise and updated information about Chagas disease, in order to increase the amount of diagnostics and treatments amongst the affected people.
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and ... more
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and ... more
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c ... more
Advances have been made through expanded interventions delivered through five public health approaches: innovative and intensified disease management; preventive chemotherapy; vector ecology and management; veterinary public health services; and the provision of safe water, sanitation and hygiene. I ... more
This fourth WHO report on neglected tropical diseases (NTDs) reviews the progress made towards achieving the Roadmap targets for 2020, noting the remaining challenges, then looks beyond 2020 to evaluate the changing global health and development landscape, considering the implications of integrating ... more
Accessed on 04.04.2023 The Drugs for Neglected Diseases initiative (DNDi) is an international non-profit organization that discovers, develops, and delivers safe, effective, and affordable treatments for the most neglected patients
L'eau potable et les services d'assainissement et d'hygiène (WASH) sont essentiels à la prévention des 17 maladies tropicales négligées (MTN) pour lesquelles une intensification de la lutte ou l'élimination sont prévues à l'horizon 2020.
La fourniture d’eau potable et de services d’ ... more
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig ... more